Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Antibody-Dependent Cell Cytotoxicity (Phase 1)
Bone Marrow Cells (Phase 1/Phase 2)
Breast Neoplasms (Phase 1/Phase 2)
Carcinoma (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Renal Cell (Phase 1/Phase 2)
Colonic Neoplasms (Phase 1/Phase 2)
Drugs, Investigational (Phase 1)
Drug Therapy (Phase 1)
Endometriosis (Phase 1)
Ependymoma (Phase 1)
Esophageal Neoplasms (Phase 1/Phase 2)
Fallopian Tube Neoplasms (Phase 1/Phase 2)
Glioblastoma (Phase 1)
Glioma (Phase 1)
Hamartoma (Phase 1/Phase 2)
Hematologic Neoplasms (Phase 1)
HIV (Phase 2)
Immunotherapy (Phase 1)
Laryngeal Neoplasms (Phase 1/Phase 2)
Leukemia (Phase 1/Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1/Phase 2)
Leukemia-Lymphoma, Adult T-Cell (Phase 1)
Leukemia, Megakaryoblastic, Acute (Phase 1/Phase 2)
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 1/Phase 2)
Leukemia, Myeloid, Acute (Phase 1/Phase 2)
Leukemia, Myeloid, Chronic-Phase (Phase 1/Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 1/Phase 2)
Liver Neoplasms (Phase 1/Phase 2)
Liver Transplantation (Phase 1/Phase 2)
Lung Neoplasms (Phase 1/Phase 2)
Lymphoma (Phase 1/Phase 2)
Lymphoma, Non-Hodgkin (Phase 1)
Medulloblastoma (Phase 1)
Melanoma (Phase 1)
Multiple Myeloma (Phase 2)
Myelodysplastic Syndromes (Phase 1/Phase 2)
Natural Killer T-Cells (Phase 1)
Neoplasms (Phase 2)
Neuroblastoma (Phase 1/Phase 2)
Ovarian Neoplasms (Phase 1/Phase 2)
Pancreatic Neoplasms (Phase 1/Phase 2)
Pneumonia (Phase 1)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1/Phase 2)
Prostatic Neoplasms (Phase 1)
Sarcoma (Phase 1/Phase 2)
Small Cell Lung Carcinoma (Phase 2)
T-Lymphocytes (Phase 1/Phase 2)
Tongue Neoplasms (Phase 1/Phase 2)
Uterine Cervical Neoplasms (Phase 1/Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue